Beverly Knight

Vectorial Transport of Fexofenadine across Caco-2 Cells: Involvement of Apical Uptake and Basolateral Efflux Transporters

Xin Ming, Beverly Knight, Dhiren R. Thakker · Molecular Pharmaceutics · 2011 · 84 citations

Vectorial Transport System, Pharmacotherapy, Digestive Tract +16

Fragment-Based Discovery of a Small Molecule Inhibitor of Bruton’s Tyrosine Kinase

Christopher R. Smith, Douglas R. Dougan, Mallareddy Komandla et al. · Journal of Medicinal Chemistry · 2015 · 73 citations · Full text

Drug Target, Bioorganic Chemistry, Tyrosine Kinase +18

A phase I pharmacokinetics study comparing PF-06439535 (a potential biosimilar) with bevacizumab in healthy male volunteers

Beverly Knight, Danielle Rassam, Shanmei Liao et al. · Cancer Chemotherapy and Pharmacology · 2016 · 50 citations · Full text

Population Pharmacokinetic Modeling of Gemtuzumab Ozogamicin in Adult Patients with Acute Myeloid Leukemia

Jennifer Hibma, Beverly Knight · Clinical Pharmacokinetics · 2018 · 21 citations

Hematological Malignancy, Oncology, Pharmacokinetic Modeling +10

P-Glycoprotein Increases Portal Bioavailability of Loperamide in Mouse by Reducing First-Pass Intestinal Metabolism

Matthew B. Dufek, Beverly Knight, Arlene S. Bridges et al. · Drug Metabolism and Disposition · 2013 · 20 citations